Levels of (S)-N′-nitrosonornicotine in U.S. tobacco products

Nicotine and Tobacco Research

Volumn 15, Issue 7, 2013, Pages 1305-1310

  Stepanov, Irina ^a,b   Yershova, Katrina ^a   Carmella, Steven ^a   Upadhyaya, Pramod ^a   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; NITROSONORNICOTINE;

ARTICLE; CHEMICAL COMPOSITION; CHIRAL CHROMATOGRAPHY; CIGARETTE TOBACCO FILLER; CONVENIENCE SAMPLE; ENANTIOMER; GAS CHROMATOGRAPHY; MOISTURE; PRIORITY JOURNAL; SMOKELESS TOBACCO; SMOKING; TOBACCO; UNITED STATES;

CHROMATOGRAPHY, GAS; NITROSAMINES; STEREOISOMERISM; TOBACCO; TOBACCO PRODUCTS; TOBACCO, SMOKELESS; UNITED STATES;

EID: 84879398747     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts249     Document Type: Article

References (28)

1. Armstrong, D. W., Wang, X., & Ercal, N. (1998). Enantiomeric composition of nicotine in smokeless tobacco, medicinal products, and commercial reagents. Chirality, 10, 587-591. doi:10.1002/(SICI)1520-636X(1998)10:7<587::AIDCHIR6> 3.0.CO;2-#
2. Armstrong, D. W., Wang, X., Lee, J. T., & Liu, Y. S. (1999). Enantiomeric composition of nornicotine, anatabine, and anabasine in tobacco. Chirality, 11, 82-84. doi:10.1002/ (SICI)1520-636X(1999)11:1<82::AID-CHIR14>3.0.CO;2-C
3. Balbo, S., James-Yi, S., O'Sullivan, G., Stepanov, I., Wang, M., Zhang, S., ... Hecht, S.S. (2012). (S)-N′-Nitrosonornicotine, a constituent of smokeless tobacco, is a potent oral tumorigen in rats. Abstracts, AACR Annual Meeting, March 31- April 4, 2012, Chicago, IL.
4. Carmella, S. G., McIntee, E. J., Chen, M., & Hecht, S. S. (2000). Enantiomeric composition of N′-nitrosonornicotine and N′-nitrosoanatabine in tobacco. Carcinogenesis, 21, 839-843. doi:10.1093/carcin/21.4.839
5. Gavilano, L. B., Coleman, N. P., Burnley, L. E., Bowman, M. L., Kalengamaliro, N. E., Hayes, A.,Siminszky, B. (2006). Genetic engineering of Nicotiana tabacum for reduced nornicotine content. Journal of Agricultural and Food Chemistry, 54, 9071-9078. doi:10.1021/jf0610458
6. Gupta, P. C., Murti, P. R., & Bhonsle, R. B. (1996). Epidemiology of cancer by tobacco products and the significance of TSNA. Critical Reviews in Toxicology, 26, 183- 198. doi: 10.3109/10408449609017930
7. Hatsukami, D. K., Ebbert, J. O., Feuer, R. M., Stepanov, I., & Hecht, S. S. (2007). Changing smokeless tobacco products new tobacco-delivery systems. American Journal of Preventive Medicine, 33(6 Suppl.), S368-S378. doi:10.1016/j. amepre.2007.09.005
8. Hecht, S. S. (1998). Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chemical Research in Toxicology, 11, 559-603. doi:10.1021/tx980005y
9. Hecht, S. S., Chen, C. B., Hirota, N., Ornaf, R. M., Tso, T. C., & Hoffmann, D. (1978). Tobacco-specific nitrosamines: Formation from nicotine in vitro and during tobacco curing and carcinogenicity in strain A mice. Journal of the National Cancer Institute, 60, 819-824.
10. Hecht, S. S., Chen, C. B., Ornaf, R. M., Jacobs, E., Adams, J. D., & Hoffmann, D. (1978). Reaction of nicotine and sodium nitrite: Formation of nitrosamines and fragmentation of the pyrrolidine ring. The Journal of Organic Chemistry, 43, 72-76.
11. Hecht, S. S., Rivenson, A., Braley, J., DiBello, J., Adams, J. D., & Hoffmann, D. (1986). Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Research, 46, 4162-4166.
12. Hecht, S. S., Stepanov, I., & Hatsukami, D. K. (2011). Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products. Tobacco Control, 20, 443. doi:10.1136/ tc.2010.037648
13. Hotchkiss, J. H. (1989). Preformed N-nitroso compounds in foods and beverages. Cancer Surveys, 8, 295-321.
14. International Agency for Research on Cancer [IARC]. (2004). Tobacco smoke and involuntary smoking. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83. Lyon, France: IARC.
15. International Agency for Research on Cancer [IARC]. (2007). Smokeless tobacco and tobacco-specific nitrosamines. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 89. Lyon, France: IARC.
16. Lao, Y., Yu, N., Kassie, F., Villalta, P. W., & Hecht, S. S. (2007). Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N′-nitrosonornicotine. Chemical Research in Toxicology, 20, 246-256. doi:10.1021/ tx060208j
17. McIntee, E. J., & Hecht, S. S. (2000). Metabolism of N′-nitrosonornicotine enantiomers by cultured rat esophagus and in vivo in rats. Chemical Research in Toxicology, 13, 192-199. doi:10.1021/tx990171l
18. Mirvish, S. S., Sams, J., & Hecht, S. S. (1977). Kinetics of nornicotine and anabasine nitrosation in relation to N′-nitrosonornicotine occurrence in tobacco and to tobaccoinduced cancer. Journal of the National Cancer Institute, 59, 1211-1213.
19. Nelson, D. E., Mowery, P., Tomar, S., Marcus, S., Giovino, G., & Zhao, L. (2006). Trends in smokeless tobacco use among adults and adolescents in the United States. American Journal of Public Health, 96, 897-905. doi:10.2105/ AJPH.2004.061580
20. Richter, P., Hodge, K., Stanfill, S., Zhang, L., & Watson, C. (2008). Surveillance of moist snuff: Total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines. Nicotine & Tobacco Research, 10, 1645-1652. doi: 10.1080/14622200802412937
21. Rogers, J. D., Biener, L., & Clark, P. I. (2010). Test marketing of new smokeless tobacco products in four U.S. cities. Nicotine & Tobacco Research, 12, 69-72. doi:10.1093/ntr/ ntp166
22. Stepanov, I., Biener, L., Knezevich, A., Nyman, A. L., Bliss, R., Jensen, J.,Hatsukami, D.K. (2012). Monitoring tobaccospecific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: Findings from Round 1 of the New Product Watch. Nicotine & Tobacco Research, 14, 274-281. doi: 10.1093/ntr/ntr209
23. Stepanov, I., Hecht, S. S., Ramakrishnan, S., & Gupta, P. C. (2005). Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. International Journal of Cancer, 116, 16-19. doi:10.1002/ijc.20966
24. Stepanov, I., Jensen, J., Hatsukami, D., & Hecht, S. S. (2008). New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels. Nicotine & Tobacco Research, 10, 1773-1782. doi:10.1080/14622200802443544
25. Stepanov, I., Knezevich, A., Zhang, L., Watson, C. H., Hatsukami, D. K., & Hecht, S. S. (2012). Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: Three decades of remarkable neglect by the tobacco industry. Tobacco Control, 21, 44-48. doi: 10.1136/tc.2010.042192
26. U.S. Federal Trade Commission. (2007). Smokeless tobacco reports for the years 2002-2005. Washington, DC: Federal Trade Commission.
27. Yuan, J. M., Knezevich, A. D., Wang, R., Gao, Y. T., Hecht, S. S., & Stepanov, I. (2011). Urinary levels of the tobacco-specific carcinogen N′-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis, 32, 1366-1371. doi:10.1093/carcin/bgr125
28. Zhang, S., Wang, M., Villalta, P. W., Lindgren, B. R., Lao, Y., & Hecht, S. S. (2009). Quantitation of pyridyloxobutyl DNA adducts in nasal and oral mucosa of rats treated chronically with enantiomers of N′-nitrosonornicotine. Chemical Research in Toxicology, 22, 949-956. doi:10.1021/tx900040j